Search results
‘ChatGPT for CRISPR’ creates new gene-editing tools
Nature· 22 hours agoSome of the AI-designed gene editors could be more versatile than those found in nature.
Scientists' research on RNA editing illuminates possible lifesaving treatments for genetic diseases
Phys.org· 8 hours agoPostdoctoral researchers Artem Nemudryi and Anna Nemudraia conducted the research alongside Blake Wiedenheft, professor in the Department of Microbiology and Cell Biology in MSU's College of ...
Can CRISPR-Cas gene editing tech fight antimicrobial resistance?
Investing.com· 2 days agoCan CRISPR-Cas gene editing tech fight antimicrobial resistance?
CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note
Zacks via Yahoo Finance· 3 days agoCRISPR Therapeutics AG (CRSP) closed the latest trading day at $53.91, indicating a +0.34% change...
Prime gets FDA green light to begin first trial test of ‘prime editing’
BioPharma Dive via Yahoo Finance· 10 hours agoThe company will soon start a Phase 1/2 study of its treatment for chronic granulomatous disease, a...
Researchers systematically investigate efficacy of CRISPR antimicrobial agents
Phys.org· 4 days agoThe researchers have conducted the first systematic interrogation of CRISPR antimicrobials using multidrug-resistant and hypervirulent bacteria as case studies, revealing ...
CRISPR is promising to tackle antimicrobial resistance, but bacteria can fight back
Phys.org· 3 days agoIn his presentation "How to use CRISPR-Cas to combat AMR" at the ESCMID Global Congress, Assistant Prof. Ibrahim Bitar, Department of Microbiology, Faculty of Medicine and ...
Enhanced CRISPR method enables stable insertion of large genes into the DNA of higher plants
Phys.org· 5 days agoThe study, led by Prof. Alain Tissier and Dr. Tom Schreiber, has been published in Molecular Plant. CRISPR/Cas is a method with enormous potential for the targeted modification ...
Experts develop way to harness CRISPR technology to deal with antimicrobial resistance
Phys.org· 3 days agoA new research review at this year's ESCMID Global Congress (formerly ECCMID—Barcelona 27–30 April)...
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Seeking Alpha· 4 days agoRegeneron Pharmaceuticals and Mammoth Biosciences join forces to develop CRISPR-based gene editing...